120 related articles for article (PubMed ID: 16738537)
1. Transcription factor Ets-1 is essential for mesangial matrix remodeling.
Mizui M; Isaka Y; Takabatake Y; Sato Y; Kawachi H; Shimizu F; Takahara S; Ito T; Imai E
Kidney Int; 2006 Jul; 70(2):298-305. PubMed ID: 16738537
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinase-9 associated with ets-1 proto-oncogene in rat tubulointerstitial cells.
Naito T; Tanihata Y; Nishimura H; Tanaka T; Higuchi C; Taguchi T; Sanaka T
Nephrol Dial Transplant; 2005 Nov; 20(11):2333-48. PubMed ID: 16046515
[TBL] [Abstract][Full Text] [Related]
3. Production and degradation of extracellular matrix in reversible glomerular lesions in rat model of habu snake venom-induced glomerulonephritis.
Kawazu T; Nishino T; Obata Y; Furusu A; Miyazaki M; Abe K; Koji T; Kohno S
Med Mol Morphol; 2012 Dec; 45(4):190-8. PubMed ID: 23224597
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.
Keeling J; Herrera GA
Kidney Int; 2005 Oct; 68(4):1590-603. PubMed ID: 16164636
[TBL] [Abstract][Full Text] [Related]
5. Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis.
Naito T; Razzaque MS; Nazneen A; Liu D; Nihei H; Koji T; Taguchi T
J Am Soc Nephrol; 2000 Dec; 11(12):2243-2255. PubMed ID: 11095647
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
7. Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.
Rao VH; Rai V; Stoupa S; Agrawal DK
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(6):H1075-86. PubMed ID: 26254334
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
Okuda S; Languino LR; Ruoslahti E; Border WA
J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
McLennan SV; Kelly DJ; Schache M; Waltham M; Dy V; Langham RG; Yue DK; Gilbert RE
Kidney Int; 2007 Aug; 72(4):481-8. PubMed ID: 17554258
[TBL] [Abstract][Full Text] [Related]
10. Possible role of Ets-1 and MMP-1 in matrix remodeling in experimental cisplatin nephropathy.
Nazneen A; Razzaque MS; Liu D; Taguchi T
Med Electron Microsc; 2002 Dec; 35(4):242-7. PubMed ID: 12658359
[TBL] [Abstract][Full Text] [Related]
11. [Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells].
Dong FQ; Li H; Wu F; Yao HP
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3444-7. PubMed ID: 19159581
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells.
Baricos WH; Cortez SL; Deboisblanc M; Xin S
J Am Soc Nephrol; 1999 Apr; 10(4):790-5. PubMed ID: 10203363
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
[TBL] [Abstract][Full Text] [Related]
14. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
[TBL] [Abstract][Full Text] [Related]
15. Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells.
Hori Y; Katoh T; Hirakata M; Joki N; Kaname S; Fukagawa M; Okuda T; Ohashi H; Fujita T; Miyazono K; Kurokawa K
Kidney Int; 1998 Jun; 53(6):1616-25. PubMed ID: 9607192
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
17. ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-beta1 stimulated glomerular podocytes.
Liu S; Liang Y; Huang H; Wang L; Li Y; Li J; Li X; Wang H
Cell Physiol Biochem; 2005; 16(4-6):207-16. PubMed ID: 16301820
[TBL] [Abstract][Full Text] [Related]
18. Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis.
Raffetseder U; Wernert N; Ostendorf T; van Roeyen C; Rauen T; Behrens P; Floege J; Mertens PR
Kidney Int; 2004 Aug; 66(2):622-32. PubMed ID: 15253715
[TBL] [Abstract][Full Text] [Related]
19. [Role of TGF-beta in glomerular diseases].
Okuda S
Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
[TBL] [Abstract][Full Text] [Related]
20. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
